Table 31.7Costs and Effects of a Specified Mental Health Care Package

World Bank region
Sub-Saharan AfricaLatin America and the CaribbeanMiddle East and North AfricaEurope and Central AsiaSouth AsiaEast Asia and the Pacific
Total effect (DALYs averted per year per 1 million population)
Schizophrenia: older antipsychotic drug plus psychosocial treatment254373364353300392
Bipolar disorder: older mood-stabilizing drug plus psychosocial treatment312365322413346422
Depression: proactive care with newer antidepressant drug (SSRI; generic)1,1741,9531,8061,7891,9371,747
Panic disorder: newer antidepressant drug (SSRI; generic)245307287307284330
Total effect of interventions1,9852,9982,7792,8622,8672,891
Total cost (US$ million per year per 1 million population)
Schizophrenia: older antipsychotic drug plus psychosocial treatment0.471.811.611.320.520.75
Bipolar disorder: older mood-stabilizing drug plus psychosocial treatment0.481.801.231.390.620.95
Depression: proactive care with newer antidepressant drug (SSRI; generic)1.804.803.993.562.812.59
Panic disorder: newer antidepressant drug (SSRI; generic)0.150.270.210.230.160.20
Total cost of interventions2.98.77.06.54.14.5
Cost-effectiveness (DALYs averted per US$1 million expenditure)
Schizophrenia: older antipsychotic drug plus psychosocial treatment544206226267574522
Bipolar disorder: older mood-stabilizing drug plus psychosocial treatment647203262298560446
Depression: proactive care with newer antidepressant drug (SSRI; generic)652407452502690675
Panic disorder: newer antidepressant drug (SSRI; generic)1,5881,1551,3391,3501,7651,649

Source: Authors' own estimates.

From: Chapter 31, Mental Disorders

Cover of Disease Control Priorities in Developing Countries
Disease Control Priorities in Developing Countries. 2nd edition.
Jamison DT, Breman JG, Measham AR, et al., editors.
Copyright © 2006, The International Bank for Reconstruction and Development/The World Bank Group.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.